Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

N-terminal hexaglutamine-tagged recombinant human N-acetylgalactosamine-6-sulfate sulfatase

EU orphan designation number: EU/3/09/615   
Active ingredient: N-terminal hexaglutamine-tagged recombinant human N-acetylgalactosamine-6-sulfate sulfatase
Indication: Treatment of mucopolysaccharidosis, type IVA (Morquio A Syndrome)
Sponsor: Dr Ulrich Granzer
Mauerkircherstrasse 105, 81925 Munich, Deutschland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
03/03/2009 Orphan Designation EMEA/OD/097/08 (2009)1521 of 27/02/2009
28/05/2009 Transfer of orphan designation EMEA/OD/097/08/T/01 (2009)4223 of 26/05/2009
18/01/2011 Transfer of orphan designation EMEA/OD/097/08/T/02 (2010)9548 of 17/12/2010
20/06/2011 Corrigendum (2011)3907 of 30/05/2011
28/05/2015 Change of address of sponsor